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Free radkds such as superoxIde ,-0,-l pmduced by ran- 
tbbw midare ndgbt cause cdl death during reperfusion 
aRer mvocardtd i&ada. The r&t of the xantbiir ori- 
ihe a&al inhibitor ofsupemxide prbdudi. To i&t nwe 
deiinttivety whether untbtw oxidasederived free mdkds 
Reactive oween snecies such as the superoxide anion 
(.O,-1, the dy&ax$ radical (.OH) and hydrogen peroxide 
(H,(X) are potentially harmful to living cells (I) and have 
been implicated as a cause of tissue injury during reperfusion 
after intestinal and cerebral ischemia 12-41, circulatory 
shock (5). organ transplantation (5). skin flap grafting (6) and 
pulmonary hyperoxia (7). Oxygen-derived free radicals have 
also been implicated as a major cause of damage during 
reoxygenation of hyponic myocardium or reptfusion of 
ischemic myocardium (8-l I). The proposed spumes of oxy- 
gen free radicds in the ischemic-reperfused heart include the 
enzyme xanthine oxidase (8). the NADPH (reduced form of 
? 2.7% (mean t SEMI bt the oxy~ wn~p ,n = 10) 
nnd 23.1 ? 4.Ik in tbe ccutml goup ,n = 17) ,p = NW 
Cdlattrat blood&w tetbebmertwetbt&oftbeixkmtc 
watt averaged 0.08 * 0.01 mtlmin per g io t!a oxypnrbmt 
group and 0.09 + 0.02 mumin per g bl tk cmdmt gmop. 
In coantmt dogs. iam.i stem “65 bwe&y related to cdlst- 
em, now 0xypiwir.d dtd UC4 aft tbk retatbn ,nndysis or 
covartance F = 0.029. p = NW. TbaF, oxypuk4 dtd WI 
nicotinamide adenine dinuckotide ghospbhate) oxidase of 
neurrophils (12). catecholamine oxidation and mitcchondrial 
respiration (13). Of these, xanthine oxidase and neutrophils 
are thought o be the most likely candidates for production of 
quantities of free radicals sufficient to cause myocardial 
iniurv durine rewrfusion (13). 
“It-is weli kn& tba repelfusion of ischemic myocar- 
dium. if accomplished within an appropriate rime frame. is 
beneficial in that it halts the advancing “wave front” OF 
irreversible cell iqjury, thus salvag& areas oftissue that are 
reversibly injured (14.15). However. it is possible that some 
tnyocytes that are viable at the end of the ischemic episode 
are killed during reperfusion. One specific mechanism 
through which such “reperfusion injury” might occur in- 
volves the enzyme xanthine oxidase (I I). During myocardial 
ischemia. adenine nucleaiides are rapidly degraded to nucle- 
aides and bases, including hypoxanthine and xanthine (16). 
lschemia also induces the conversion of the enzyme xan- 
thine dehydrogenase to xanthine oxidase (17). Xanthine 
oxidasc forms superoxide anions and hydrogen peroxide by
reducing molecular oxygen during the conversion of hype 
xanthine to xanthine and xanthine to uric acid Reintroduc- 
tion of oxygen by repelfusion might cause increased forma- 
tion of such reactive oxygen species that could further injure 
viable myocytes or mi&&lamre. If xanfhine aid&e- 
derived free radicals do cause myocyte death, either directly 
or because ofmicrovascular injury during reperfusion, myo- 
cardial protection, and thus infarct size limitation, should be 
achieved by inhibition of the enzyme. 
The effect of the xanthine oxidase inhibitor allopurinol on 
infarct size has been variable in a number of studies 
(8,lWO). Infarct size limitation war observed in studies in 
which allopwinol treatment was begun I8 to 24 h before 
occlusion (8,18,19). However, a previous study fmm this 
laboratory (20) showed no limitation of infarct size in an 
iachemia-reperfusion model when allopurinol treatment was 
begun 30 min before occlusion. it has been suggested (19.21) 
that prolonged pretreatment with allopurinol may be neces- 
sary for protection of the myocardium because a significant 
amount of time is required to form axypurinol, the actual 
inhibitor of superoxide pmduction by xanthine oxidase (22). 
lfthis is true, it could account for the failure ofallopurinol to 
limit infarct size in our previous study. To clarify whether 
lack ofpretreatment was responsible for the negative results 
of that study and whether xanthine oxidase-derived free 
radicals cause myocyte death during repetiwion. a new 
study was performed with the same experimental model but 
using shoti-term pretreatment with oxypurinol. 
Methods 
Animal seleeliott and surgical procedures. This tudy con- 
formed to the American Physiological Societv’s guidelines 
for the use of laboratory a&nals..wenty-three &It mon- 
aeel dogs of either sex (pregnant female dogs were excluded) 
were used. The dogs weighed between 9 and 25 kg, had a 
hematocrit of ~33% and had no clinical evidence of infec- 
tion. They were anesthetized with 30 to 40 mdkg body 
weight of sodium pentobarbital. and ventilated using a 
Harvard (model 607) animal respirator with 200 ml/kg per 
min of room air supplemented with low Row oxygen. Ven- 
tilatory and oxygen flow retes were adjusted as needed to 
maintain ate&-blood gas values within normal physiologic 
ranges. Penicillin (750,ooO U) was given intramuscularly and 
aseptic surgical techniques were used throughout each ex- 
periment. Polyethylene catheters were placed in the right 
femoral afiery and vein. The arterial catheter was used to 
monitor blood pressure with a Stathem P23 DE! pressure 
transducer and to withdraw blood for blood gas &sure- 
mew for determination of plasma oxypurinol concentra- 
tion and for reference samples for measurement of myocar- 
dial blood flow by radioactive micmspheres (considered 
later in this report). The venous catheter was used to 
administer treatment dnlg or placebo as well as additional 
anesthetic as needed. 
A left thoracotomy was performed through the fourth 
intercostal space and the heart was suspended in a p&car- 
dial cradle. The left atrial appendage was snared and the left 
circumflex coronary artery was isolated distal to its atrial 
appendage branch but proximal to its first large marginal 
branch. A piece of umbilical tape was passed around the 
anery for later occlusion; occlusion was accomplished by 
snaring the artery in a small plastic tube. Two polyethylene 
catheters were placed in the left atrium by way of its 
appendage, one for measurement of left atrial pressure and 
one for injection of radioactive microspheres for meawe- 
ment of myocardial blood flow. Tween 80 (polysorbate 80. a 
surfactant) was administered (0.0596, 0.6 ml) through the 
latter catheter to desensitize the animal before the first 
injection of microsphere suspensions containing this deter- 
gent. Left atrial pressure. arterial presso~~ lead 11 of the 
standard electro&diogram (ECG) Ad pericardial tempera- 
ture were monitored throughout the experiment on a Gould 
(model 2400) recorder. Tlte dogs were allowed at least I5 min 
after surgical preparation to reach steady state. 
The lefi circumJ?ex coronary orrery was occluded, as 
previously described. .fgr 40 min. Occlusion was confirmed 
by ECG changes, an &ease in left atrial pressure and by 
visual inspection for cyanosis. After 40 min the occlusion 
was abruptly released to establish reflow, which was con- 
tirmed by ECG changes. visual inspection for reactive hy- 
peremia and visual inspection of the artery. If ventricular 
fibrillation developed during ischemia or reflow cardiover- 
sion was performed, if possible, with use ofinternal paddles 
and an MRL (model 564J) defibrillator. At the end of the 
experimental protocol, all catheters were removed, the chest 
and femoral incisions were closed, air was evacuated from 
the chest and the dogs wre allowed to survive for 4 days to 
sllow histologic delineatiori of the infarct. On the 4th PCS!- 
operative. day, the dogs were reanesthetized with pmtobar- 
bital and given heparin (S,OMl U intravenously) to prevent 
formation of intravascular thrombi. The heart was then 
excised for postmortem analysis (see later). 
Exprimentrd design (Fig. 1). Dogs underwent 40 min of 
left circumflex coronary artery occlusion followed bv reper- 
fusion for 4 days. Treated dogs (n = tZ) were gi&. ;wo 
intravenous doses of oxypurinol. each dose being IO m&g. 
The first dose was given IO min before elusion and the 
second 10 min before repafusion. Oxypurinol was dissolved 
in pH IO normal saline solution and each dose was adminis- 
tered as a 5 mt$ml solution given over I to 2 min. Control 
dogs (n = I I) received a similar dose of pH IO normal saline 
solution alone. Additional control dogs (n = 9) from a 
concurrent study were included to increase group size. The 
protocol under which these dogs were studied was identical 
except that they received an intraatrial infusion of albumin 
and sucrose in normal saline solution beginning 15 min after 
Rgure 1. Erpimental protacal. Dogs ““derwent a 40 min OEEllt 
sion Of the ckc”mdex FOro”ary anery. Mpmdlil blood ROW 
(MFJFJ was measured IS min and 5 rnin before occlwion and 10 min 
afterocclusion. tlxypur nol (Dxy) was infused over 2 min at 10 mm 
before occlusion and 10 min before rcperfunion. Blwd samples fur 
measurement of plasma oxypurinol (PI concentration were drawn I 
min before and 10 tin atIer reperfusion. Dogs were allowed to 
survive for 4 days and were then killed. 
the start of a 40 min occlusion and ending 35 min after 
reperfusion. These two subgroups of confrol dogs did not 
differ significantly in hemodynamic data. blood flow, size of 
cennarion of oxypurinol were drawn before administration 
of the first drug dose and I min before and IO min after the 
onset of repcrfusion. 
Myocardiaf blood pow was measured 5 min before ad- 
ministration ofthe first dose of oxypurinol or saline solution. 
5 mitt after that dose (5 mitt before occlusion) and 10 min 
after occlusion. 
Measttremeotv OI re&n.al myacardld b!+orl Bow. Re- 
gional mycardial blood flow VI& measured by the micm- 
sphere technique. The microspheres were obtained from 
stock solutions containing 0.05% Tween 80 and 10% dextran 
and. before use, were agitated ultrasonically and with a 
vortexer to prevent clumping. At the times previously indi- 
cated, 2 to 3 million IO + 2 wtt radioactive microspheres. 
labeled with ‘SC (scandium). “‘Sn (tin) or “‘Gd lgadoli- 
Gum) (New England Nuclear), were injected through the 
catheter in the let? atrial appendage fotlowed by a I5 ml 
saline Rush. A rcfcrcm.e sample of arterial blood was col- 
lected with the femoral artery catheter at7.75 ml per min for 
2.5 min beginning just before injection of microspheres. 
Sample tadioactivity was measured on a Packard (model 
5912) gamma courder with corrections made for werlap af 
isotopi spectra. 
The primary experimental end point was histologic infarct 
size, which was analyzed with respect to major baseline 
predictors of infarct size, including the area at risk and 
collateral blood Row (14,231. 
Area at risk. To define the anatomic boundaries of the 
previously ixhemic and nonischemic vascular beds, cathe 
ters were placed in the letI main coronary artery and in the 
Reeinral htood Row. Flow measurements were made in 
the remaining pations of the basal six ventricular slices (see 
diaerams in reference 20~241. The slices were divided into 
n&chemic and central ischemic regions. Lateral and septal 
border zones were excluded to avoid possible misinterpre- 
tation of measurements from samples that contained a mix- 
ture of ischemic and nonischemic tissue. The nonischemic 
: and central ischemic regions were subdivided intc three 
left circumflex corottary artery at the sate of the previous layers: rubendocardial (inner third), midmyocaxdial third 
occlusion: both vessels were perfused simultaneously with 
dye solutions at 120 to MO nun Hg pressure. The perfusion 
fluid was sodium phosphate buffer (0.09 M, pH = 7.4) with 
8% dextan (molecular weight 82,Mw, Sigma Chemical Com- 
pany) added to preverd edema during perfusion. The perfus- 
ate to the previously ischemic circum8ex bed contained 
triphenyltetrazolium chloride (TTC, I%. Sigma Chemical 
Company). whereas that to the nonischenic vascutm bed 
(by way of the left main artery) contained Moaastrat blue 
dye (0.5%. DuPont). The perfused heart was incubated at 
37°C m normal saline solution for 20 min and then fixed by 
immersion in a large volume of phosphate-buffered fomxlin 
(pH 7.0). After fixation for a minimum of 48 h, the left 
ventricle was cut into e’:ht transverse slices that were 
weighed and the apical surfaces were photographed. An 
enlarged projection of the photographic slide of each slice 
was traced, including the boundaries of the previously 
ischemic vascular bed (area at risk of infarction). The areaat 
risk was then measured by “cut and weigh” techniques 
using photocopies of these tracings (14). The wright of 
ischemic myocardium in each slice was calculated on the 
basis of mean ischemic area of the apical and basal surfaces. 
Althowh only the a&d surfaces were photographed, the 
basal &acewas cowidered to be the n&or&e of the 
apical surface ofthe adjacent slice. Overall area at risk was 
calculated as the weight of ischemic tissue in all eight slices 
divided by the total weight of all eight slices, and is en- 
pressed as a percent of the left ventricle. 
Infarct she. Infarct size was measured on the basis of 
histologic evaluation of representative slices through the 
infarct and adjoining regions. The method of sampling for 
histologic analysis has been described previously (see dia- 
grams in reference 20 or 24). Briefly, the apical halves of five 
of the eight ventricular slices were used to prepare histolcgic 
slides. These tissue sections were stained with Heidenhein’s 
variant of Mallory’s connective !issue stain. Enlarged pro- 
jectionr of the tissue on the histologic slides were traced. as 
were the necrotic areas within the section. The fractional 
areas of necrotic and viable tissue in each section were 
calculated by cut and weigh techniques using photocopies of 
the tracings. These fractional areas were converted to gnms 
using the known weight of the myocardial b ock represented 
by each histologic section. Infarct size was then calculated 
as a percent of the entire left ventricle and as a percent of the 
area rd risk. 
and subepicardial (outer third). Regional myocardial blood no significant difference in mortality between the groups. 
Row was calculated using the formula: Tissue Row = (Tissue Two of the oxypurinol-treated ogs developed ventricular 
counts, IReference AowVRcference coo”ts, and was ex- fibrillation. one during occlusion md one during reperfusion. 
pressed relative to sample weight (milliliters per minute per In neither was cardi&ersion successful. Four control dogs 
gram). Corrections were made for apparent microsphere loss developed ventricular fibrillation during both occlusiott and 
in nine dogs (four control and five treated dogs) that had reperfusion. Ail underwent successful cardioversiun and 
preacclusion ischemic-nonischemic region flow ratios survived 4 days but one was withdrawn from the study when 
cO.90. This allows for correction of blood flow values that deRbrillator bums precluded analysis of infarct size. Four 
are arlifactually low. and infarct and area at risk sizes that control doss developed ventricular fibrillation during reper- 
are artifactually high as a resuit ofedema, inflammatory cells fusion only. Three underwent cardioversion and survived 4 
and hemorrhage within the region of infarction (25). Preoc- days. and one died as a result of defibrillator malfunction. 
elusion blood flows are expressed as transmural mean vel. The eight surviving control dogs from the concurrent study 
“es. Collateral blood Row is measured in each of the three had mean values for size of the area at risk, collateral blood 
myocardial layers. To use collateral Row as a baseline Row and infarct size as a percent of the area et risk that were 
predictor of infarct size we calculated Row in the inner two simikuto the mean values for the oine surviving control dogs 
thirds of the ischemic wall linner DIUS midmyocardiall; these from tbis study. There were no sirmificant hemodvnamic 
are the zones at greatest risk of ;nfarction huring a 40 min differences between the two cootroigroups. Thus, io oxy- 
period of ischemia. One control dog was excluded from the purinol-treated and I7 control dogs are included in statistical 
study because it did not develop severe subendocardial comparisons. Table I provides re&lts for each of the 27 dogs 
ischemia after coronary occlusion (subendocardial collateral as well as group means. 
blood flow 0.39 ml/& per g). 
Measurement of plasma owurinol concentration. Blood 
samples for measurement of &ma concentration of oxy- 
purinol were drawn from all dogs that received oxypurinol. 
The blood samples were centrifuged for IO min at I .MHlg and 
the plasma was removed and frozen for analysis at B later 
date. During analysis. the predrug sample was spiked with a 
stock solution of oxypurinol before protein precipitation to 
give a 0.10 mM (IS.2 @/ml) standard. Concentration f the 
stock solution was adjusted spectrophotometrically at 252 
nm. Perchloric acid was added to the samoles to oreci&de 
plasma protein. Analysis was performed in a Ch&anetics 
2.5 cm column with 5 um Soherirorb ODS-2 oackine. The 
mobile phase was 0.05’M at&onium aceta.te.~pH 6.0. with 
1% acetonitrile. A Waters HPLC (high performance liquid 
chromatography) system was used (models 840 HPLC. 496 
detector and 7108 sample processor). 
Statistics. Data are expressed as group means * SEM. 
Statistical comparisons of group means were made with 
Student’s two-tailed I test. Paired r tests were used to detect 
any changes in rexional blood flow or hemodvnamic varia- 
bles indoied by d&g or placebo. To control fo; variability in 
infarct size due to differences in collateral blood flow, the 
Oxypurinol ~coatewtlatiotts and hemodynsmic clleets. 
Plasma concentration of ox~purinol in the 10 surviving 
treated dogs averaged 17.3 ? i,~,.&ol I min beforeand l2.i 
* 0.8 &ml IO min after the onset of reperfusion. Adminis- 
tration of the first dose of oxypurinol was associated with 
small but statistically significant increases in systolic and 
diastolic blood pressure (from 170 + Ml29 + 4 to 174 ? 61134 
+ 4 mm Hg). Control dogs showed statistically significant 
increases in systolic blood pressure (from I51 t- IO to IS5 + 
9 mm Hg) and rate-pressure product (fmm 2.52 + 28 to 258 + 
26. rate-pressure product/lOO) after administration of pH IO 
saline solution. Baseline myocardial bled Row to bath the 
circumflex and the nonischemic vascular beds was not 
significantly different between groups. Administration of the 
first dose of oxypurinol was asso&ated with a small but 
statistically significant increase in transmural mean blood 
Row to the circumflex artery bed (from I .36 ? 0. I I to I .48 ? 
0.14 mlimin per g, p < 0.01) and to the nonischemic bed 
(from 1.32 C 0.13 to 1.47 + 0.16 mllmin per g. p 4 0.005). 
Administration of pH IO normal saline solution to the control 
dogs was not associated with e significant increase in myo- 
cardial blood flow. 
Baseline oredietors of infarct size. Hemodvnamic data for 
regression of infwct size versus collateral blood Row was the two groups are summarized in Figure.2. The groups 
evaluated and an analysis ofcovariance was performed using differed signiticantlr (I~IIY in weocclusion diastolic blood 
collateral flow as the independent variable and infarct size es pressure, which wei slightly lower in cotttrol dogs. No other 
the dependent variable. A p valoe CO.05 was considered hcmodynamic differences were noted throughout the study. 
statistically significant. ‘I/w size of the ma 01 risk is our oJlhs major baseline 
prrdicrors ofbrfnrcr size. Area at risk was similar in the two 
Results 
Animal surviml. Twenty-three dogs were randomized 
into the study, I2 into the group treated with oxyporinol and 
I I into the control group receiving saline solution. There was 
groups. averaging 37.1 + 1.2% of the left ventricle in the 
control group and 38.4 f 1.3% in the treated group (Table I. 
Fig. 3). 
Collnrer~d blodjlos is smrhrr major boselinv predrtor 
ofinf&t size. Mean collawrel flow to the inner two thins of 
the ischemic wall was similar in both groups. averaging U&Y 4.2% in lh: control group and 23.8 r 2.7% in Ihe treated 
2 0.02 mllmin per g in the control group and 0.M 2 0.01 group (p = NS) (Fig. 3). 
mllmin per g in the oxypurinal group Ip = NS) (Fig. 3). I1 Tlv rrl,rrir~n henwon bzfnrcr sire and collafmd blood 
was not possible to examine the effect of oxypurinol or pH J/w is show in Figwrl. As has been observed in previous 
IO saline solution on collateral flow in this experimenKd ,tudirs (14 2023.24). there WBP an inverse relation between 
protocol because treatment was initiated before coronaiy infarct size and collateral flow: dogs with low collateral ROW 
occlusion. had large ,nfarcts and dogs with high collateral Row had 
Infarct size. To conlrol for variation in area at risk. small infarcts. Inspection of Figure 4 suggests hat oxypuri- 
infarct size was expressed as a percent of the area itL risk; nol did not shift the relation demonslrated by the control 
this was not different between groups. averaging 23.1 ? group. ‘This was confirmed by an analysis of covariance 
Figora 2. Hemodyoamic data in ecatrol and axw~rinui-trealed 
dogs. BL = basrlinc. measured before 6rd myocardial blood Row 
measuremen,: DBP = diastolic blood pressure; MIN = minutes of 
using collateral Row as the independent variable and infarct 
size as the dcocndent variable IF = 0.029. o = NS). This 
analysis controls for variability of collateral bloob Row 
nmong dogs. Thus, oxypurinol clearly had no effect on 
infarct size in this model of ischemia and reperfusion. 
Discussion 
Summary of rationale and resulb of present study. A 
mcvious stud” from our laboratory (20) showed that short- 
;erm pretreat&~ with allopurinoi(bcginning 30 min before 
coronary occlusion) had no effect on the size of infarcts 
produced by 40 min of ischemia and 4 days of rcperfusion. 
However. ulher investiaalors G3.18.IY) have ranted dra- 
matic protective cff&in studies using allop&ol when 
treatment was begun 18 to 24 h before occlusion. 11 has been 
suggested that short-term pretreatment with allopurinol 
might not allow sut7icient time fw its conversion to oxypu- 
rinol. tbe actual inhitiitar of superoxide production. 
figure 4. lnfaret size versus collateral blood Row in the treated and 
control crouos. The relation bctwcca infwet size. exoressed as a 
percent oftbe area at drk, and collawal blood ROW to ihc inner ND 
thirds of the ischemic wall is illustrated. Each win1 wresentl one 
dog. Control and oxygtinol-treated ogs d&onstraicd a similar 
inverse relation between i farct size and collateral Row. Analysis of 
eovarinnce using collateral Row as the independent variable PIS~ 
indicated no significant dikence between the two groups. 0 = 
cmtrol: 0 = onypurinol; A = control ,Co”c”rrent mldY). 
When allopurinol is administered, it initially assoeiatcs 
with the oxidized form of xanihine oxidare in a compelilive 
manner (competing with the substrates hypoxanthine and 
xanthine). Then. acting as an alternate substrate. it is rapidly 
converted to oxypurinol, producing supcroxidc anions or 
hydrogen peroxide, or both. The oxypurinol is bound to the 
reduced form of the enzyme and the axypurinol-xanthine 
onidasc complex undergoes rearrangement to fomt a much 
more stable complex. Hypoxanlhine and xanthine do not 
significantly impede the binding of oxypurinolf26). Thus, in 
terms of hypoxanlhine and xattthine catabolism. alloputinol 
is a competitive inhibitor. However, with regard to soper- 
oxide production, allopurinol is actually a substrate. not an 
inhibitor, Oxypurinol is the compound that inhibits supcrox- 
ide production by the enzyme (22). (The possibility that free 
radicals produced by conversion of allopurinol to oxypurinol 
could injure the myocardium seems udikely. because most 
of this conversion will occur outside the myocardium in 
tissues with higher xanthine oxidasc activity. such as the 
gut.) 
To test more definitively whether xamhine oxidase- 
derived free radicals contribute to myocytc death during 
ischemia with reperfusion. we conduclcd the present study 
using short-term treatment with oxypurinol, thus avoiding 
the potentkal dosing uncertainties encountered when using 
allopurinol. The results of this study oppose the hypothesis 
that xanthine oxidase-derived free radicals cause cell death 
during reperfusion of ixhemie myocardium. Dogs that were 
trcated with the xanthinc oxida inhibitor oxypurinol be- 
ginning 10 mio before coronary occlusion developed mfarctn Go. Chamber< et al. (8) and Wems et al. (19) reported that 
that were the same average size as those in a saline-treeted inhlbnion of xanthine oxidase with allopurinol significantly 
control group. The results support the CO~C~UE~O~ of our bmited mfarct size after transient coro~;dry occlusions of tXl 
previous study (20) and also are consistent with the res~I1~ of and 90 min. respectively. As noted earlier. a previous study 
another recent study from our laboratory (24) in which from our laboratory (20) found that allopurinol had no elect 
administmdon of the free radical scavenging enzyme super- on the size of infarcts produced by 40 min coronary c&u- 
oxide dismutase failed to limit myocardial infarct size after stons. Puett el al. (31) recently reponed that oxy~urinol did 
40 min of ischcmia followed by 4 days of reperfusion. These not limit infarct size after 90 min of ischemia and 24 h of 
two studies indicate that superoxide radicals are not a major reperfusion. In a study using pemvment coronery occlu- 
cause of myoeyte death in this model. s~ons. Aktzuki et al. (18) repOrted that allopurinol substan- 
Critique of methods. fiperimenlul model. To evaluate tially limited the size of infarcts induced by 24 h of ischemia. 
these results fully, it is useful to consider several spects of The reason or reasons why the results of this study and of
the experimental design and methods. The dog is an XQQ~O- our previous study (20) differ from those from several other 
priate species to use because it has xamhine oxidase in the laboratories is not clear. Differences in drug dosingprotocols 
~yocarhium (8). unlike the rabbit, pig and guinea pig. wh!ch 
have no detectable xanthine oxidase activity (27-29). The 40 
min duration of occlusion provides a test of the effect of 
therapy on cell death within the se~xrely ischcmic subendo- 
cardial region; the less severely izrhczic mid- and subepi- 
cardial regions are salvaged by reperfusion irrespective of 
the presence or absence of therapy. This 413 min occlusion 
and reperfusion model meets several specific requirements 
to tesi the hypothesis that some ischemic myocyte~ are 
killed in the early phase of reperfusion because of a burst of 
oxygen-centered &ee radicals from the xanthine oxidase 
reaction: I) a substantial fraction of xmtrhine dehydrogenase 
is converted to xanthine oxidase during the ischemic period 
(8,17): 2) accumulation of the purine substrates hypoxan- 
thine and xanthine is greatest in the subendocardium. where 
washout by collateral blood Row is least (30): and 3) large 
amounts of molecular oxygen, the other substrate. are 
introduced during reperfusion. 
Baseline predictors of infarct size. infarct size varies 
substantially among dogs without relation to any treatment 
given. Most of this variation in infarct size has been shown 
to be related to variation in the size of the ischemic area at 
risk of infarction and to the amount of collateral blood flaw 
tolhisarcaat risk (l4,23). In the present study we controlled 
for these two baseline predictors of infwet size. Infarct size 
was eXFr.Sed as a percent of the area at risk. Collateral 
blood Row was measured in each dog and the relation 
between it&at sile and collateral flow was analyzed. With 
such analyses, it has been determined that a IO to 13% 
limitation of infarct size could be detected 50% of the time 
using experimental groups of I5 dogs eaco (23). A more 
substantial protective tTect would be more readily detected. 
Converselv. when collateral Row is not measured in <very 
using allopurinol dc w! appear to be the reason berawe we 
ahse.ved no limitation of infarct size when oxypurinal, the 
actual mhibi!or of xanthine oxidase. was administered 
acutely in an adequate dose. 
Methodologk di&rences among experinwttal m&k. 
There are veveral technical differences among these studies 
that should be considered. In studies reporting Qositive 
effects (8.lR.19L infarcts were sized grossly on the basis of 
distribution of tetmmlium stainina. Tetrazolium staininr 
results from cmymatic activity within the myocardium ani 
does not necessarily indicate tissue viability (32). In this and 
our previous nllop&nol study. infarct s&war measured on 
the basis of histologic evaluation f fully developed necrosis. 
It is our opinion that histo!ogic examination provides the 
most reliable measure of infarct size. Another difference 
among studies concerns the measurement of collateral blood 
Row. Two studies (18.19) that reported infarct size limitation 
with allopurinol did not me&e collateral Row in control 
and treated dogs: thus it is not certain that the two groups 
had campardbly severe iscbemia. Collateral Row was mea- 
sured in the study by Chambers et al. (8). but the relation 
between infarct size and collateral Row in their treatment 
and control groups was not evaluated. In the negative study 
by Puett et al. (31). a regression anatysir of infarct size 
VCRUS collateral blood flow showed oxy~urinol did not shift 
the relation exhibited by contml hearts. 
II is porsibk rhnr there IS n biologic basis Jnr lhese 
discrvpmr resrdrs as a result of the diierent experimental 
designs employed in each. Among the models that have 
included reprfusion, the duration of irchemia and reperfu- 
Pion. as well as the means of establishing roperfusion. have 
been variable. However. variation in the duration of ische- 
mia does not appear to explain the discrepancies regarding 
animal and used to predict infarct size, it is possible to draw the effect of xanthine axidase inhibition on infarct size. 
spurious conclusions because of undetected inequalities in Positive results have been reported in studies using occlu- 
&line characteristics that may occur in small~groups of sions of 60 min (8) and 90 min (19). whereas negative results 
dogs (20.23). have been reported with occlusions of 40 min (20, present 
Xrmtbine midase and irreversible injury. A number of study) and 9Omin (31). 
studies have addressed the possible role of xanthine oxidare ~l,u rwlmique by which rcperfk~n is essteblished also 
in causing myocardial necrosis during ischemia and reperfu- roaU irlJlrrcncr de amotmt of free mdktds produced. For 
example, Werns et al. (19) performed repelfusion in the 
presence of a critical coronary stenosir. which prevented 
reactive hvoeremia. It is wssible that this critical stenosis 
slowed th;khout of hy~oaanthine and xaothine from the 
ischemic region. and thereby allowed a longer time for free 
radical production. 
The drrarion of reperfusion aho hns been variable nmong 
/hew studies. Infarct size limitation was observed when 
reperfusion lasted 4 h (8) or 6 h (19) but not I day (31) or 4 
days (20). These results are consistent with the possibility 
that short-term xanthine oxidase inhibition is protective in 
the early phases of repetfusion, but that the salvaged myo- 
cardium undergoes necrosis later in repetfusion, that is, 
delayed “reperfusion injury.” The resulls of studies using 
treatment with superoxide dismutase are less consistent. 
Although infarct size limitation was seen with short (4 to 6 h) 
reperfusion periods (8.33). such an et&t sometimes WBE 
(34,35) and sometimes was not (24,361 observed when rewr- 
fusion lasted I to 4 days. Thus. though the duration of 
reperfusion might determine whether infarct size limitation 
occurs with an intervention such as acute administration of 
allopurinol. oxypurinol or superoxide dismutase, no clear 
pattern has yet emerged. 
Conclusions. It has been suggested that allopwinal failed 
to limit infarct size in our previous study because the drug 
was not administered early enough to allow conversion to 
oxypurinol, the actual inhibitor of superoxide produclion by 
xanthine oxidase. We have circumvented this potential 
pitfall by direct administration of oxypurinol: nevertheless. 
infarct size was not a&ted. Thus, the results of this study 
and those of previous studies using the same experimental 
model oppose the hypothesis that xanthine oxidase-derived 
free radicals contribute to myocyte death during 40 min of 
ischemia followed by 4 days of repelfusion. 

